Indeed, as shown in Figure 4F, while a robust increase in the expression of N-cadherin was detected in patients with advanced gastric cancer (p<0.05), no significant changes were found in terms of expression of E-cadherin or vimentin (Figure 4D and 4E). This evidence concerns the gene CDH2 and gastric cancer.